No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
www.fujipharma.jpNo one on the platform currently holds 4554.T.
No tracked institution reports a position in 4554.T as of their last filing.
No one on the platform has traded 4554.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.3% | 4.9% | 6.5% | — | — | — |
| Rev. Growth % | 12.0% | 8.9% | ||||
| Profit Margin % | 5.8% | 8.5% | 8.1% | |||
| Free Cash Flow Margin % | 7.4% | -0.6% | 4.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $60.3B | +21.4% | $75.65 | $55.60–$95.70 | — | 2 |
| 2027 | $66.7B | +10.6% | $211.40 | $181.60–$241.20 | — | 2 |
| 2028 | $72.6B | +8.8% | $236.25 | $204.50–$268.00 | — | 2 |
| 2029 | $77.1B | +6.1% | $248.40 | $228.42–$268.38 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4554.TFuji Pharma Co., Ltd. | $1802.00 | +2.62% | $47.1B | — |
| 219A.THeartseed, Inc. | $2435.00 | -0.29% | $55.7B | — |
| 3183.TWIN-Partners Co., Ltd. | $1264.00 | -0.08% | $34.8B | — |
| 4577.TDaito Pharmaceutical Co.,Ltd. | $1289.00 | +1.34% | $37.1B | — |
| 4595.TMizuho Medy Co.,Ltd. | $1718.00 | +0.47% | $32.7B | — |
| 5592.TKusurinomadoguchi, Inc. | $2694.00 | -0.99% | $30.9B |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| 6062.TCharm Care Corporation | $1424.00 | +0.14% | $46.5B | — |